First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.

about

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases.

Item

http://www.wikidata.org/entity/Q55384028

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

First pediatric experience of ...... oplasm: report of three cases.

@en

First pediatric experience of ...... oplasm: report of three cases.

@nl

type

Item

label

First pediatric experience of ...... oplasm: report of three cases.

@en

First pediatric experience of ...... oplasm: report of three cases.

@nl

prefLabel

First pediatric experience of ...... oplasm: report of three cases.

@en

First pediatric experience of ...... oplasm: report of three cases.

@nl

P1476

First pediatric experience of ...... oplasm: report of three cases.

@en

P2093

Anna Pawlowska

http://www.w3.org/2001/XMLSchema#string

Anthony Stein

http://www.w3.org/2001/XMLSchema#string

Debbie Toomey

http://www.w3.org/2001/XMLSchema#string

Huaying Liu

http://www.w3.org/2001/XMLSchema#string

Joseph Rosenthal

http://www.w3.org/2001/XMLSchema#string

Nicole Karras

http://www.w3.org/2001/XMLSchema#string

Wade Kyono

http://www.w3.org/2001/XMLSchema#string

Weili Sun

http://www.w3.org/2001/XMLSchema#string

Young Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population: A Case Series and Review of the Literature

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia.

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond.

P2888

s13045-018-0604-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S13045-018-0604-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul S. Gaynon

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103769130

http://www.w3.org/2001/XMLSchema#string

P698

29720227

http://www.w3.org/2001/XMLSchema#string

P921

blastic plasmacytoid dendritic cell neoplasm

P932

5932872

http://www.w3.org/2001/XMLSchema#string